Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 4/2013

01.08.2013 | Clinical Investigation

Pattern of Retained Contrast on Immediate Postprocedure Computed tomography (CT) After Particle Embolization of Liver Tumors Predicts Subsequent Treatment Response

verfasst von: Xiaodong Wang, Joseph P. Erinjeri, Xiaoyu Jia, Mithat Gonen, Karen T. Brown, Constantinos T. Sofocleous, George I. Getrajdman, Lynn A. Brody, Raymond H. Thornton, Majid Maybody, Ann M. Covey, Robert H. Siegelbaum, William Alago, Stephen B. Solomon

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine if the pattern of retained contrast on immediate postprocedure computed tomography (CT) after particle embolization of hepatic tumors predicts modified Response Evaluation Criteria in Solid Tumors (mRECIST) response.

Materials and Methods

This study was approved by the Institutional Review Board with a waiver of authorization. One hundred four liver tumors were embolized with spherical embolic agents (Embospheres, Bead Block, LC Bead) and polyvinyl alcohol. Noncontrast CT was performed immediately after embolization to assess contrast retention in the targeted tumors, and treatment response was assessed by mRECIST criteria on follow-up CT (average time 9.0 ± 7.7 weeks after embolization). Tumor contrast retention (TCR) was determined based on change in Hounsfield units (HUs) of the index tumors between the preprocedure and immediate postprocedure scans; vascular contrast retention (VCR) was rated; and defects in contrast retention (DCR) were also documented. The morphology of residual enhancing tumor on follow-up CT was described as partial, circumferential, or total. Association between TCR variables and tumor response were assessed using multivariate logistic regression.

Results

Of 104 hepatic tumors, 51 (49 %) tumors had complete response (CR) by mRECIST criteria; 23 (22.1 %) had partial response (PR); 21 (20.2 %) had stable disease (SD); and 9 (8.7 %) had progressive disease (PD). By multivariate analysis, TCR, VCR, and tumor size are independent predictors of CR (p = 0.02, 0.05, and 0.005 respectively). In 75 tumors, DCR was found to be an independent predictor of failure to achieve complete response (p < 0.0001) by imaging criteria.

Conclusion

TCR, VCR, and DCR on immediate posttreatment CT are independent predictors of CR by mRECIST criteria.
Literatur
1.
Zurück zum Zitat Dhanasekaran R, Kooby DA, Staley CA et al (2010) Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC). J Surg Oncol 101(6):476–480 Dhanasekaran R, Kooby DA, Staley CA et al (2010) Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC). J Surg Oncol 101(6):476–480
2.
Zurück zum Zitat Kim JH, Yoon HK, Ko GY et al (2010) Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization. Radiology 255(1):270–277PubMedCrossRef Kim JH, Yoon HK, Ko GY et al (2010) Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization. Radiology 255(1):270–277PubMedCrossRef
3.
Zurück zum Zitat Nazario J, Gupta S (2010) Transarterial liver-directed therapies of neuroendocrine hepatic metastases. Semin Oncol 37(2):118–126PubMedCrossRef Nazario J, Gupta S (2010) Transarterial liver-directed therapies of neuroendocrine hepatic metastases. Semin Oncol 37(2):118–126PubMedCrossRef
4.
Zurück zum Zitat Malagari K, Pomoni M, Spyridopoulos TN et al (2011) Safety profile of sequential transcatheter chemoembolization with DC Bead: results of 237 hepatocellular carcinoma (HCC) patients. Cardiovasc Intervent Radiol 34(4):774–785PubMedCrossRef Malagari K, Pomoni M, Spyridopoulos TN et al (2011) Safety profile of sequential transcatheter chemoembolization with DC Bead: results of 237 hepatocellular carcinoma (HCC) patients. Cardiovasc Intervent Radiol 34(4):774–785PubMedCrossRef
5.
Zurück zum Zitat Liapi E, Geschwind JF (2010) Chemoembolization for primary and metastatic liver cancer. Cancer J 16(2):156–162PubMedCrossRef Liapi E, Geschwind JF (2010) Chemoembolization for primary and metastatic liver cancer. Cancer J 16(2):156–162PubMedCrossRef
6.
Zurück zum Zitat Lencioni R, de Baere T, Burrel M et al (2011) Transcatheter treatment of hepatocellular carcinoma with doxorubicin-loaded DC Bead (DEBDOX): technical recommendations. Cardiovasc Intervent Radiol 35:980–985PubMedCrossRef Lencioni R, de Baere T, Burrel M et al (2011) Transcatheter treatment of hepatocellular carcinoma with doxorubicin-loaded DC Bead (DEBDOX): technical recommendations. Cardiovasc Intervent Radiol 35:980–985PubMedCrossRef
7.
Zurück zum Zitat Tadavarthy SM, Knight L, Ovitt TW et al (1974) Therapeutic transcatheter arterial embolization. Radiology 112(1):13–16PubMed Tadavarthy SM, Knight L, Ovitt TW et al (1974) Therapeutic transcatheter arterial embolization. Radiology 112(1):13–16PubMed
8.
Zurück zum Zitat Allison DJ, Modlin IM, Jenkins WJ (1977) Treatment of carcinoid liver metastases by hepatic-artery embolisation. Lancet 2(8052–8053):1323–1325PubMedCrossRef Allison DJ, Modlin IM, Jenkins WJ (1977) Treatment of carcinoid liver metastases by hepatic-artery embolisation. Lancet 2(8052–8053):1323–1325PubMedCrossRef
9.
Zurück zum Zitat Bonomo G, Pedicini V, Monfardini L et al (2010) Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up. Cardiovasc Intervent Radiol 33(3):552–559PubMedCrossRef Bonomo G, Pedicini V, Monfardini L et al (2010) Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up. Cardiovasc Intervent Radiol 33(3):552–559PubMedCrossRef
10.
Zurück zum Zitat Covey AM, Maluccio MA, Schubert J et al (2006) Particle embolization of recurrent hepatocellular carcinoma after hepatectomy. Cancer 106(10):2181–2189PubMedCrossRef Covey AM, Maluccio MA, Schubert J et al (2006) Particle embolization of recurrent hepatocellular carcinoma after hepatectomy. Cancer 106(10):2181–2189PubMedCrossRef
11.
Zurück zum Zitat Maluccio MA, Covey AM, Porat LB et al (2008) Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 19(6):862–869PubMedCrossRef Maluccio MA, Covey AM, Porat LB et al (2008) Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 19(6):862–869PubMedCrossRef
12.
Zurück zum Zitat Lewis AL, Adams C, Busby W et al (2006) Comparative in vitro evaluation of microspherical embolisation agents. J Mater Sci Mater Med 17(12):1193–1204PubMedCrossRef Lewis AL, Adams C, Busby W et al (2006) Comparative in vitro evaluation of microspherical embolisation agents. J Mater Sci Mater Med 17(12):1193–1204PubMedCrossRef
13.
Zurück zum Zitat Uchida H, Matsuo N, Nishimine K et al (1993) Transcatheter arterial embolization for hepatoma with lipiodol—Hepatic arterial and segmental use. Semin Intervent Radiol 10(1):19–26CrossRef Uchida H, Matsuo N, Nishimine K et al (1993) Transcatheter arterial embolization for hepatoma with lipiodol—Hepatic arterial and segmental use. Semin Intervent Radiol 10(1):19–26CrossRef
14.
Zurück zum Zitat Choi BI, Kim HC, Han JK et al (1992) Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: cT and pathological findings. Radiology 182(3):709–713PubMed Choi BI, Kim HC, Han JK et al (1992) Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: cT and pathological findings. Radiology 182(3):709–713PubMed
15.
Zurück zum Zitat Tognolini A, Louie JD, Hwang GL et al (2010) Utility of C-arm CT in patients with hepatocellular carcinoma undergoing transhepatic arterial chemoembolization. J Vasc Interv Radiol 21(3):339–347PubMedCrossRef Tognolini A, Louie JD, Hwang GL et al (2010) Utility of C-arm CT in patients with hepatocellular carcinoma undergoing transhepatic arterial chemoembolization. J Vasc Interv Radiol 21(3):339–347PubMedCrossRef
16.
Zurück zum Zitat Vogl TJ, Trapp M, Schroeder H et al (2000) Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success—Results from a liver transplantation center. Radiology 214(2):349–357PubMed Vogl TJ, Trapp M, Schroeder H et al (2000) Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success—Results from a liver transplantation center. Radiology 214(2):349–357PubMed
17.
Zurück zum Zitat Takayasu K, Muramatsu Y, Maeda T et al (2001) Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 176(3):681–688PubMedCrossRef Takayasu K, Muramatsu Y, Maeda T et al (2001) Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 176(3):681–688PubMedCrossRef
18.
Zurück zum Zitat Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30(1):52–60PubMedCrossRef Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30(1):52–60PubMedCrossRef
19.
Zurück zum Zitat Berber E, Foroutani A, Garland AM et al (2000) Use of CT Hounsfield unit density to identify ablated tumor after laparoscopic radiofrequency ablation of hepatic tumors. Surg Endosc 14(9):799–804PubMedCrossRef Berber E, Foroutani A, Garland AM et al (2000) Use of CT Hounsfield unit density to identify ablated tumor after laparoscopic radiofrequency ablation of hepatic tumors. Surg Endosc 14(9):799–804PubMedCrossRef
20.
Zurück zum Zitat Herber S, Biesterfeld S, Franz U et al (2008) Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Cardiovasc Intervent Radiol 31(4):768–777PubMedCrossRef Herber S, Biesterfeld S, Franz U et al (2008) Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Cardiovasc Intervent Radiol 31(4):768–777PubMedCrossRef
21.
Zurück zum Zitat Fujita T, Ito K, Tanabe M et al (2008) Iodized oil accumulation in hypervascular hepatocellular carcinoma after transcatheter arterial chemoembolization: comparison of imaging findings with CT during hepatic arteriography. J Vasc Interv Radiol 19(3):333–341PubMedCrossRef Fujita T, Ito K, Tanabe M et al (2008) Iodized oil accumulation in hypervascular hepatocellular carcinoma after transcatheter arterial chemoembolization: comparison of imaging findings with CT during hepatic arteriography. J Vasc Interv Radiol 19(3):333–341PubMedCrossRef
22.
Zurück zum Zitat Kloeckner R, Otto G, Biesterfeld S et al (2010) MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 33(3):532–540PubMedCrossRef Kloeckner R, Otto G, Biesterfeld S et al (2010) MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 33(3):532–540PubMedCrossRef
23.
Zurück zum Zitat Moschouris H, Malagari K, Papadaki MG et al (2010) Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads: a pilot study focused on sustained tumor necrosis. Cardiovasc Intervent Radiol 33(5):1022–1027PubMedCrossRef Moschouris H, Malagari K, Papadaki MG et al (2010) Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads: a pilot study focused on sustained tumor necrosis. Cardiovasc Intervent Radiol 33(5):1022–1027PubMedCrossRef
24.
Zurück zum Zitat Sze DY, Razavi MK, So SK et al (2001) Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma. AJR Am J Roentgenol 177(6):1339–1345PubMedCrossRef Sze DY, Razavi MK, So SK et al (2001) Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma. AJR Am J Roentgenol 177(6):1339–1345PubMedCrossRef
25.
Zurück zum Zitat Iwazawa J, Ohue S, Mitani T et al (2009) Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography. AJR Am J Roentgenol 192(4):1057–1063PubMedCrossRef Iwazawa J, Ohue S, Mitani T et al (2009) Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography. AJR Am J Roentgenol 192(4):1057–1063PubMedCrossRef
Metadaten
Titel
Pattern of Retained Contrast on Immediate Postprocedure Computed tomography (CT) After Particle Embolization of Liver Tumors Predicts Subsequent Treatment Response
verfasst von
Xiaodong Wang
Joseph P. Erinjeri
Xiaoyu Jia
Mithat Gonen
Karen T. Brown
Constantinos T. Sofocleous
George I. Getrajdman
Lynn A. Brody
Raymond H. Thornton
Majid Maybody
Ann M. Covey
Robert H. Siegelbaum
William Alago
Stephen B. Solomon
Publikationsdatum
01.08.2013
Verlag
Springer New York
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 4/2013
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-012-0506-x

Weitere Artikel der Ausgabe 4/2013

CardioVascular and Interventional Radiology 4/2013 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.